Business
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
ZUG, Switzerland, September 11, 2025--Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking place in Paris, September 17-20, 2025. Highlighting its commitment to addressing skin conditions across the dermatology spectrum, Galderma will present 12 abstracts, including data on sensitive skin, prurigo nodularis, and atopic dermatitis, and host a variety of e
About this update from Galderma Group Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":823,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/2058e73d45b92f3d2db1e2a47bf25be4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ilJeDK6fIEDeo1XITsrB2w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/2058e73d45b92f3d2db1e2a47bf25be4","width":823,"height":209},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/KZs_e1HRyNm1u0M7Gkf_4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NDY7aD00MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/2058e73d45b92f3d2db1e2a47bf25be4","width":823,"height":209}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Galderma will present a wealth of data including new findings showing the impact of modern living on sensitive skin and insights from the largest global survey conducted on the condition","length":186,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Late-breaking data on Nemluvio’s® (nemolizumab) mode of action in atopic dermatitis (AD) and long-term safety and efficacy data in prurigo nodularis (PN) and moderate-to-severe AD up to two years will also be presented, supporting its potential as a frontline treatment that addresses key disease symptoms1-5","length":308,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The company will also host a symposium on itch, industry hubs on sensitive skin and acne, and multiple Meet the Expert sessions, demonstrating its ongoing commitment to healthcare professional education and clinical excellence","length":226,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":720,"olType":false},{"type":"text","content":"ZUG, Switzerland, September 11, 2025--(BUSINESS WIRE)--Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking place in Paris, September 17-20, 2025. Highlighting its commitment to addressing skin conditions across the dermatology spectrum, Galderma will present 12 abstracts, including data on sensitive skin, prurigo nodularis, and atopic dermatitis, and host a variety of events – from industry hubs on sensitive skin and acne, to a sympo...